Top Policies for Fostering Healthcare Innovation

Value-Based Reimbursement incentivizes healthcare providers to focus on patient quality and outcomes, rather than the volume of services. This encourages the adoption of new technologies and innovative approaches that improve treatment effectiveness and efficiency.

• Pays providers based on quality and efficiency of care

• Improves health experience and outcomes

Tax incentives for healthcare startups reduce the initial financial burden, allowing these companies to reinvest capital into research and development. This accelerates the creation of new medical technologies and treatments, directly driving innovation in the healthcare sector.

• Attracts private investment

• Promotes the creation of skilled jobs

• Accelerates the development of new technologies

• Enhances sector competitiveness

A Streamlined FDA Approval Process accelerates the market entry of new medical therapies and technologies. By reducing bureaucratic times and complexity, developers are incentivized to invest in research and development, thereby driving innovation in the healthcare sector.

• Streamlines regulatory review processes.

Interoperable Electronic Health Records are crucial for fostering innovation by enabling seamless data exchange between different health systems and providers. This connectivity facilitates research, the development of new therapies, and improved patient care through large-scale data analysis.

• Provides the ability to import/export data in the European format for electronic health record exchange

• Allows a patient's medical information to be available across different levels and facilities

• Guarantees the patient's right to access their reports and tests

• Enables the exchange of clinical data between different healthcare providers

Increased Funding for Research and Development is crucial for the advancement of the healthcare sector. By allocating more resources to R&D, scientific discoveries are driven and new medical technologies and treatments are developed, which directly fosters innovation.

• Increases the percentage of funded medicines

• Reduces days to funding decision

• Increases funding by 32% compared to the previous one